Join us at one of our upcoming symposiums and learn how to implement different evidence-based interventions for hepatitis C (HCV) and HIV in your setting, such as point-of-care testing, dried blood spot testing, peer support, care navigation and medical record auditing.
Showcase good practice
Be inspired by examples of different interventions for HCV and HIV across a variety of settings.
Highlight latest research
Find out about the latest research about interventions to enhance the care cascade.
Build on your own model of care
Experts will support you to implement new interventions to your existing models of care for HCV and HIV.
Build new connections
We will help you make connections with experts and like-minded colleagues from across the country.
Who is it for?
This event is for anyone in the United States interested in implementing or scaling up interventions for HCV or HIV in their service setting, including doctors, nurses, frontline workers, peer workers, pharmacists and pharmacy staff, policy makers, and any other staff working in drug and alcohol or primary care settings.
After attending this event, you will be able to:
- Identify areas for enhancing or scaling up in your own HCV service delivery
- Understand how a variety of interventions for HCV and HIV work
- Identify suitable interventions to enhance your own HCV and HIV service delivery
- Describe how the intervention could be implemented in your service setting
- Analyze possible barriers to implementing interventions and how to overcome them
Upcoming Symposia
Phoenix, Arizona, September 20, 2026
- Time: 9:30am-3:00pm (all catering provided)
- Venue: Sheraton Phoenix Downtown, 340 N 3 Street, Phoenix, AZ 85004
- This Symposium is held adjacent to the 2026 Doing it in the Desert: Viral Hepatitis & STI Elimination Summit (DID2026). More information found HERE.
Webinar recordings
A Community of Practice, including a series of webinars featuring best practice case studies, is held alongside the in-person symposia, and open to anyone in the United States interested in implementing or scaling up HCV interventions. To be alerted of upcoming webinars sign up to our newsletter.
HCV Elimination Community of Practice – Prisons and Jails – September 17 2025
HCV Elimination Community of Practice – Street Medicine, April 2 2025
Past events
Lansing, Michigan, April 29, 2026
United States Steering Committee
The program is developed and delivered in collaboration with many partners. With thanks to our co-chairs, the National Alliance of State & Territorial AIDS Directors (NASTAD) and the Coalition for Global Hepatitis Elimination (CGHE) and well as our National Expert Steering Committee:
- Jordan Akerley
Strategic Director, End Hep C SF - Jasmine West
Manager, Hepatitis, NASTAD - Isabel Lechuga,
Associate Director, Hepatitis, NASTAD - John Ward
Director, Coalition for Global Hepatitis Elimination, The Task Force for Global Health - Lindsey Hiebert
Associate Director, Coalition for Global Hepatitis Elimination, The Task Force for Global Health - Natasha Martin
Professor, Division of Infectious Diseases and Global Public Health, University of California San Diego - Alain Litwin
Executive Director, Addiction Medicine Center, Prisma Health | Professor of Medicine, University of South Carolina School of Medicine | Professor, Clemson University School of Health Research | Vice Chair of Academics and Research, Prisma Health -
Cody A. Chastain
Assistant Dean, Associate Professor of Medicine, Division of Infectious Diseases | Principal Investigator, Southeast AIDS Education and Training Center, Vanderbilt University School of Medicine | Vanderbilt University Medical Center
- Matthew Akiyama
Associate Professor of Medicine Divisions of General Internal Medicine & Infectious Diseases, Albert Einstein College of Medicine - Anthony Martinez
Associate Professor of Medicine, Jacobs School of Medicine, University at Buffalo | Medical Director, Hepatology, Erie County Medical Center - Judith Feinberg
Vice Chair, Research & Professor, Infectious Diseases, West Virginia University - Oluwaseun Falade-Nwulia,
Associate Professor, Division of Infectious Diseases, John Hopkins - Adrienne Simmons
Pharmacist, Director of Programs, National Viral Hepatitis Roundtable - Ronni Marks
Founder, Director, The Hepatitis C Mentor and Support Group-HCMSG | Patient Advocate - Kyle Miller
Addiction Medicine & Family Medicine Physician, Bridgeport, West Virginia
Partners
2025 Sponsors
With thanks to our 2025 series sponsors, AbbVie and Gilead Sciences. Sponsorship is governed by our Sponsorship Policy and the sponsors have no control over content, tone, emphasis, allocation of funds or selection of recipients. INHSU does not endorse or promote any sponsor’s product or service.
